메뉴 건너뛰기




Volumn 105, Issue 12, 2011, Pages 1939-1945

Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia

Author keywords

Antibiotic therapy; Antibiotics; Children; Community acquired pneumonia; Pediatrics; Procalcitonin

Indexed keywords

ANTIBIOTIC AGENT; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE; PROCALCITONIN;

EID: 81155155586     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2011.09.003     Document Type: Article
Times cited : (132)

References (32)
  • 1
    • 80052844728 scopus 로고    scopus 로고
    • Management of severe community-acquired pneumonia of children in developing and developed countries
    • [Epub Oct 21]
    • N. Principi, and S. Esposito Management of severe community-acquired pneumonia of children in developing and developed countries Thorax 2010 [Epub Oct 21]
    • (2010) Thorax
    • Principi, N.1    Esposito, S.2
  • 2
    • 50849142594 scopus 로고    scopus 로고
    • Viruses in community-acquired pneumonia in children aged less than 3 years old. High rate of viral coinfection
    • G. Cilla, E. Oñate, E.G. Perez-Yarza, M. Montes, D. Vicente, and E. Perez-Trallero Viruses in community-acquired pneumonia in children aged less than 3 years old. High rate of viral coinfection J Med Virol 890 2008 1843 1849
    • (2008) J Med Virol , vol.890 , pp. 1843-1849
    • Cilla, G.1    Oñate, E.2    Perez-Yarza, E.G.3    Montes, M.4    Vicente, D.5    Perez-Trallero, E.6
  • 4
    • 0024508619 scopus 로고
    • Problems in determining the etiology of community-acquired childhood pneumonia
    • D. Isaacs Problems in determining the etiology of community-acquired childhood pneumonia Pediatr Infect Dis J 8 1989 143 148 (Pubitemid 19077616)
    • (1989) Pediatric Infectious Disease Journal , vol.8 , Issue.3 , pp. 143-148
    • Isaacs, D.1
  • 5
    • 0034960275 scopus 로고    scopus 로고
    • Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia
    • DOI 10.1183/09031936.01.17202410
    • S. Esposito, F. Blasi, F. Bellini, and L. Allegra Principi N and the Mowgli study group. Characteristics of Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia Eur Resp J 17 2001 241 245 (Pubitemid 32600583)
    • (2001) European Respiratory Journal , vol.17 , Issue.2 , pp. 241-245
    • Esposito, S.1    Blasi, F.2    Bellini, F.3    Allegra, L.4    Principi, N.5
  • 6
    • 0038811604 scopus 로고    scopus 로고
    • Paediatric community-acquired pneumonia: Current concept in pharmacological control
    • DOI 10.1517/14656566.4.5.761
    • N. Principi, and S. Esposito Paediatric community-acquired pneumonia: current concepts in pharmacological control Expert Opin Pharmacother 4 2003 761 777 (Pubitemid 36622206)
    • (2003) Expert Opinion on Pharmacotherapy , vol.4 , Issue.5 , pp. 761-777
    • Principi, N.1    Esposito, S.2
  • 9
    • 0029038562 scopus 로고
    • Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children
    • H. Nohynek, E. Valkeila, M. Leinonen, and J. Eskola Erythrocyte sedimentation rate, white blood cell count and serum C-reactive protein in assessing etiologic diagnosis of acute lower respiratory infections in children Pediatr Infect Dis J 14 1995 484 490
    • (1995) Pediatr Infect Dis J , vol.14 , pp. 484-490
    • Nohynek, H.1    Valkeila, E.2    Leinonen, M.3    Eskola, J.4
  • 10
    • 0030923195 scopus 로고    scopus 로고
    • White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children
    • M. Korppi, T. Heikanen-Kosma, and M. Leinonen White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children Eur Resp J 10 1997 1125 1129 (Pubitemid 27201820)
    • (1997) European Respiratory Journal , vol.10 , Issue.5 , pp. 1125-1129
    • Korppi, M.1    Heiskanen-Kosma, T.2    Leinonen, M.3
  • 11
    • 0033944279 scopus 로고    scopus 로고
    • Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children
    • DOI 10.1097/00006454-200007000-00003
    • P. Toikka, K. Irjala, T. Juvén, R. Virkki, J. Mertsola, and M. Leinonen Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children Pediatr Infect Dis J 19 2000 598 602 (Pubitemid 30469764)
    • (2000) Pediatric Infectious Disease Journal , vol.19 , Issue.7 , pp. 598-602
    • Toikka, P.1    Irjala, K.2    Juven, T.3    Virkki, R.4    Mertsola, J.5    Leinonen, M.6    Ruuskanen, O.7
  • 14
    • 75749153278 scopus 로고    scopus 로고
    • Is procalcitonin better than C-reactive protein for early diagnosis of bacterial pneumonia in children?
    • D.A. Khan, A. Rahman, and F.A. Khan Is procalcitonin better than C-reactive protein for early diagnosis of bacterial pneumonia in children? J Clin Lab Anal 24 2010 1 5
    • (2010) J Clin Lab Anal , vol.24 , pp. 1-5
    • Khan, D.A.1    Rahman, A.2    Khan, F.A.3
  • 15
    • 0037214481 scopus 로고    scopus 로고
    • Serum procalcitonin concentrations in bacterial pneumonia in children: A negative result in primary healthcare settings
    • DOI 10.1002/ppul.10201
    • M. Korppi, S. Remes, and T. Heiskanen-Kosma Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings Pediatr Pulmonol 35 2003 56 61 (Pubitemid 36009014)
    • (2003) Pediatric Pulmonology , vol.35 , Issue.1 , pp. 56-61
    • Korppi, M.1    Remes, S.2    Heiskanen-Kosma, T.3
  • 16
    • 0035007015 scopus 로고    scopus 로고
    • Serum procalcitonin in pneumococcal pneumonia in children
    • DOI 10.1183/09031936.01.17406230
    • M. Korppi, and S. Remes Serum procalcitonin in pneumococcal pneumonia in children Eur Respir J 17 2001 623 627 (Pubitemid 32492548)
    • (2001) European Respiratory Journal , vol.17 , Issue.4 , pp. 623-627
    • Korppi, M.1    Remes, S.2
  • 17
    • 70249096300 scopus 로고    scopus 로고
    • CAPNETZ Study Group. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: Results from the German competence network CAPNETZ
    • S. Krüger, S. Ewig, J. Papassotiriou, J. Kunde, R. Marre, and H. von Baum CAPNETZ Study Group. Inflammatory parameters predict etiologic patterns but do not allow for individual prediction of etiology in patients with CAP: results from the German competence network CAPNETZ Respir Res 10 2009 65
    • (2009) Respir Res , vol.10 , pp. 65
    • Krüger, S.1    Ewig, S.2    Papassotiriou, J.3    Kunde, J.4    Marre, R.5    Von Baum, H.6
  • 18
    • 77952273695 scopus 로고    scopus 로고
    • ProHOSP Study Group. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: A prospective cohort trial
    • F. Müller, M. Christ-Crain, T. Bregenzer, M. Krause, W. Zimmerli, and B. Mueller ProHOSP Study Group. Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial Chest 138 2010 121 129
    • (2010) Chest , vol.138 , pp. 121-129
    • Müller, F.1    Christ-Crain, M.2    Bregenzer, T.3    Krause, M.4    Zimmerli, W.5    Mueller, B.6
  • 19
    • 1342265610 scopus 로고    scopus 로고
    • Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: Cluster-randomised, single-blinded intervention trial
    • DOI 10.1016/S0140-6736(04)15591-8
    • M. Christ-Crain, D. Jaccard-Stolz, R. Bingisser, M.M. Gencay, P.R. Huber, and M. Tamm Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial Lancet 363 2004 600 607 (Pubitemid 38264177)
    • (2004) Lancet , vol.363 , Issue.9409 , pp. 600-607
    • Christ-Crain, M.1    Jaccard-Stolz, D.2    Bingisser, R.3    Gencay, M.M.4    Huber, P.R.5    Tamm, M.6    Muller, B.7
  • 20
    • 34547911350 scopus 로고    scopus 로고
    • Müller B for the ProHOSP study group. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: A prospective, multicenter, randomized controlled trial
    • P. Schuetz, M. Christ-Crain, M. Wolbers, U. Schild, R. Thomann, and C. Falconnier Müller B for the ProHOSP study group. Procalcitonin guided antibiotic therapy and hospitalization in patients with lower respiratory tract infections: a prospective, multicenter, randomized controlled trial BMC Health Serv Res 7 2007 102
    • (2007) BMC Health Serv Res , vol.7 , pp. 102
    • Schuetz, P.1    Christ-Crain, M.2    Wolbers, M.3    Schild, U.4    Thomann, R.5    Falconnier, C.6
  • 21
    • 54049112259 scopus 로고    scopus 로고
    • Procalcitonin-guided antibiotic vs standard approach for acute respiratory tract infections in primary care
    • M. Briel, P. Schuetz, B. Mueller, J. Young, U. Schild, and C. Nusbaumer Procalcitonin-guided antibiotic vs standard approach for acute respiratory tract infections in primary care Arch Intern Med 168 2008 2000 2007
    • (2008) Arch Intern Med , vol.168 , pp. 2000-2007
    • Briel, M.1    Schuetz, P.2    Mueller, B.3    Young, J.4    Schild, U.5    Nusbaumer, C.6
  • 22
    • 65949114287 scopus 로고    scopus 로고
    • Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission - A randomized trial
    • K.B. Kristoffersen, O.S. Sgaard, C. Wejse, F.T. Black, T. Greve, and B. Tarp Antibiotic treatment interruption of suspected lower respiratory tract infections based on a single procalcitonin measurement at hospital admission - a randomized trial Clin Microbiol Infect 15 2009 481 487
    • (2009) Clin Microbiol Infect , vol.15 , pp. 481-487
    • Kristoffersen, K.B.1    Sgaard, O.S.2    Wejse, C.3    Black, F.T.4    Greve, T.5    Tarp, B.6
  • 23
    • 70149088214 scopus 로고    scopus 로고
    • Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections. The ProHOSP randomized controlled trial
    • P. Schuetz, M. Christ-Crain, R. Thomann, C. Falconnier, M. Wolbers, and I. Widmer Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections. The ProHOSP randomized controlled trial JAMA 302 2009 1059 1066
    • (2009) JAMA , vol.302 , pp. 1059-1066
    • Schuetz, P.1    Christ-Crain, M.2    Thomann, R.3    Falconnier, C.4    Wolbers, M.5    Widmer, I.6
  • 24
    • 77952426755 scopus 로고    scopus 로고
    • Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: A post study survey
    • P. Schuetz, M. Batschwaroff, F. Dusemond, W. Albrich, U. Bürgi, and M. Maurer Effectiveness of a procalcitonin algorithm to guide antibiotic therapy in respiratory tract infections outside of study conditions: a post study survey Eur J Clin Microbiol Infect Dis 29 2010 269 277
    • (2010) Eur J Clin Microbiol Infect Dis , vol.29 , pp. 269-277
    • Schuetz, P.1    Batschwaroff, M.2    Dusemond, F.3    Albrich, W.4    Bürgi, U.5    Maurer, M.6
  • 25
    • 77956563149 scopus 로고    scopus 로고
    • Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection
    • O. Burkhardt, S. Ewig, U. Haagen, S. Giersdorf, O. Hartmann, and K. Wegscheider Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection Eur Respir J 36 2010 601 607
    • (2010) Eur Respir J , vol.36 , pp. 601-607
    • Burkhardt, O.1    Ewig, S.2    Haagen, U.3    Giersdorf, S.4    Hartmann, O.5    Wegscheider, K.6
  • 26
    • 75949113583 scopus 로고    scopus 로고
    • PRORATA trial group. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): A multicentre randomised controlled trial
    • L. Bouadma, C.E. Luyt, F. Tubach, C. Cracco, A. Alvarez, and C. Schwebel PRORATA trial group. Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial Lancet 375 2010 463 474
    • (2010) Lancet , vol.375 , pp. 463-474
    • Bouadma, L.1    Luyt, C.E.2    Tubach, F.3    Cracco, C.4    Alvarez, A.5    Schwebel, C.6
  • 28
    • 85009011369 scopus 로고    scopus 로고
    • Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in childhood
    • British Thoracic Society Standards of Care Committee. British Thoracic Society guidelines for the management of community acquired pneumonia in childhood Thorax 57 Suppl. 1 2002 i1 i24
    • (2002) Thorax , vol.57 , Issue.SUPPL. 1
    • Thoracic Society, B.1
  • 29
  • 30
    • 0036527637 scopus 로고    scopus 로고
    • Emerging resistance to antibiotics against respiratory bacteria: Impact on therapy of community-acquired pneumonia in children
    • DOI 10.1016/S1368-7646(02)00018-3, PII S1368764602000183
    • S. Esposito, and N. Principi Emerging resistance to antibiotics against respiratory bacteria: impact on therapy of community-acquired pneumonia in children Drug Res Up 5 2002 73 87 (Pubitemid 35024270)
    • (2002) Drug Resistance Updates , vol.5 , Issue.2 , pp. 73-87
    • Esposito, S.1    Principi, N.2
  • 31
    • 0037034267 scopus 로고    scopus 로고
    • Community-acquired pneumonia in children
    • K. McIntosh Community-acquired pneumonia in children N Engl J Med 346 2002 429 437
    • (2002) N Engl J Med , vol.346 , pp. 429-437
    • McIntosh, K.1
  • 32
    • 34250628847 scopus 로고    scopus 로고
    • Effective treatment strategies for paediatric community-acquired pneumonia
    • DOI 10.1517/14656566.8.8.1091
    • M. Atkinson, M. Yanney, T. Stephenson, and A. Smyth Effective treatment strategies for paediatric community acquired pneumonia Expert Opin Pharmacother 8 2007 1091 1101 (Pubitemid 46929302)
    • (2007) Expert Opinion on Pharmacotherapy , vol.8 , Issue.8 , pp. 1091-1101
    • Atkinson, M.1    Yanney, M.2    Stephenson, T.3    Smyth, A.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.